Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    NIAID | Recruiting | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus
Show Display Options
Rank Status Study
21 Recruiting Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction
Conditions: Liver Transplant Recipient;   Living Donor (of the Respective Liver Transplant Recipient)
Interventions: Biological: darTregs;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Immunosuppression (IS) Withdrawal;   Procedure: Study Mandated Procedures
22 Recruiting Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Condition: Liver Transplantation
Interventions: Biological: Anti-Thymocyte Globulin - Rabbit;   Biological: darTreg Infusion;   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Prednisone;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Anti-Infective Prophylaxis;   Procedure: Leukapheresis;   Procedure: Blood draws;   Procedure: Liver biopsies;   Procedure: Liver transplantation
23 Recruiting Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics
Condition: Asthma
Intervention: Biological: Segmental airway allergen challenge
24 Recruiting Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma
Condition: Asthma
Intervention:
25 Recruiting Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Conditions: Heart Transplant;   Small Intestine Transplant;   Kidney Transplant;   Liver Transplant;   Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder;   PTLDs
Interventions: Procedure: transplant;   Drug: Immunosuppressive Drugs
26 Recruiting Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation
Conditions: Piebaldism;   Idiopathic Anaphylaxis;   Allergy;   Chronic Urticara;   Angioedema
Intervention:
27 Recruiting Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Conditions: Kidney Transplant;   Adult Living Donor Kidney Transplant Recipients;   Renal Transplant;   Living Kidney Donor
Interventions: Biological: Polyclonal Regulatory T Cells;   Biological: Donor-Alloantigen-Reactive Regulatory T Cells;   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Mycophenolic acid;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Procedure: Biopsy, Kidney;   Procedure: Blood Draw;   Procedure: Leukapheresis;   Procedure: IS regimen conversion
28 Recruiting CLAD Phenotype Specific Risk Factors and Mechanisms.
Condition: Lung Transplant
Interventions: Procedure: Blood Draw;   Procedure: Bronchoscopy
29 Recruiting Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus
Condition: Asthma
Interventions: Drug: omalizumab;   Biological: Rhinovirus (strain 16)
30 Recruiting A Cohort Study of Operationally Tolerant Allograft Recipients
Conditions: Kidney Transplant;   Liver Transplant
Intervention: Procedure: Blood Draw
31 Recruiting School Inner-City Asthma Intervention Study (SICAS-2)
Condition: Asthma
Interventions: Other: integrated pest management;   Other: air purifier;   Other: No intervention (control)
32 Recruiting Molecular Basis of Food Allergy
Conditions: Food Allergy;   Eosinophilic Esophagitis
Intervention:
33 Recruiting Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Allergic Asthma
Condition: Allergic Asthma
Interventions: Device: CREON2000A;   Device: Sham
34 Recruiting Collection of Samples and Data for the National Marrow Donor Program Repository
Condition: Post BMT
Intervention:
35 Recruiting Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Hematopoietic and Lymphoid Cell Neoplasm;   HIV Infection
Interventions: Other: Laboratory Biomarker Analysis;   Procedure: Leukapheresis
36 Recruiting Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis
Conditions: Systemic Scleroderma;   Severe Systemic Sclerosis
Interventions: Drug: fludarabine phosphate;   Drug: Mycophenolic Acid;   Drug: tacrolimus;   Radiation: total-body irradiation;   Procedure: bone marrow transplantation;   Procedure: reduced intensity allogeneic hematopoietic stem cell transplantation;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis;   Other: flow cytometry;   Procedure: biopsy;   Drug: cyclophosphamide
37 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
38 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
Intervention:
39 Recruiting Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
Condition: Atopic Dermatitis
Intervention:
40 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.